Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 193 to 203 of 203 entries
Sorted by: Best Match Show Resources per page
How Does Tube Size Affect Patients' Experiences of Postoperative Sore Throat and Hoarseness? A Randomised Controlled Blinded Study.

Journal of clinical medicine

Christiansen P, Pedersen CH, Selter H, Odder L, Riisager JP, Damgaard K, Westmark S, Bruun NH, Melgaard D.
PMID: 34945142
J Clin Med. 2021 Dec 13;10(24). doi: 10.3390/jcm10245846.

Sore throat (POST) and hoarseness (PH) are common complaints after endotracheal intubation (EI). The aim of this study was to investigate whether tube size impacts the experiences of POST and PH after EI in patients undergoing elective surgery, as...

Cite
Christiansen P, Pedersen CH, Selter H, et al. How Does Tube Size Affect Patients' Experiences of Postoperative Sore Throat and Hoarseness? A Randomised Controlled Blinded Study. J Clin Med. 2021;10(24)doi: 10.3390/jcm10245846.
Christiansen, P., Pedersen, C. H., Selter, H., Odder, L., Riisager, J. P., Damgaard, K., Westmark, S., Bruun, N. H., & Melgaard, D. (2021). How Does Tube Size Affect Patients' Experiences of Postoperative Sore Throat and Hoarseness? A Randomised Controlled Blinded Study. Journal of clinical medicine, 10(24), . https://doi.org/10.3390/jcm10245846
Christiansen, Pia, et al. "How Does Tube Size Affect Patients' Experiences of Postoperative Sore Throat and Hoarseness? A Randomised Controlled Blinded Study." Journal of clinical medicine vol. 10,24 (2021). doi: https://doi.org/10.3390/jcm10245846
Christiansen P, Pedersen CH, Selter H, Odder L, Riisager JP, Damgaard K, Westmark S, Bruun NH, Melgaard D. How Does Tube Size Affect Patients' Experiences of Postoperative Sore Throat and Hoarseness? A Randomised Controlled Blinded Study. J Clin Med. 2021 Dec 13;10(24). doi: 10.3390/jcm10245846. PMID: 34945142; PMCID: PMC8708773.
Copy Download .nbib Format: NLM
Effectiveness of the population-based 'check your health preventive programme' conducted in a primary care setting: a pragmatic randomised controlled trial.

Journal of epidemiology and community health

Bjerregaard AL, Dalsgaard EM, Bruun NH, Norman K, Witte DR, Stovring H, Maindal HT, Sandbæk A.
PMID: 34145078
J Epidemiol Community Health. 2022 Jan;76(1):24-31. doi: 10.1136/jech-2021-216581. Epub 2021 Jun 18.

BACKGROUND: Health checks have been suggested as an early detection approach aiming at lowering the risk of chronic disease development. This study aimed to evaluate the effectiveness of a health check programme offered to the general population, aged 30-49...

Cite
Bjerregaard AL, Dalsgaard EM, Bruun NH, et al. Effectiveness of the population-based 'check your health preventive programme' conducted in a primary care setting: a pragmatic randomised controlled trial. J Epidemiol Community Health. 2021;76(1):24-31doi: 10.1136/jech-2021-216581.
Bjerregaard, A. L., Dalsgaard, E. M., Bruun, N. H., Norman, K., Witte, D. R., Stovring, H., Maindal, H. T., & Sandbæk, A. (2022). Effectiveness of the population-based 'check your health preventive programme' conducted in a primary care setting: a pragmatic randomised controlled trial. Journal of epidemiology and community health, 76(1), 24-31. https://doi.org/10.1136/jech-2021-216581
Bjerregaard, Anne-Louise, et al. "Effectiveness of the population-based 'check your health preventive programme' conducted in a primary care setting: a pragmatic randomised controlled trial." Journal of epidemiology and community health vol. 76,1 (2022): 24-31. doi: https://doi.org/10.1136/jech-2021-216581
Bjerregaard AL, Dalsgaard EM, Bruun NH, Norman K, Witte DR, Stovring H, Maindal HT, Sandbæk A. Effectiveness of the population-based 'check your health preventive programme' conducted in a primary care setting: a pragmatic randomised controlled trial. J Epidemiol Community Health. 2022 Jan;76(1):24-31. doi: 10.1136/jech-2021-216581. Epub 2021 Jun 18. PMID: 34145078.
Copy Download .nbib Format: NLM
Patient's perception of recovery after sinus membrane elevation and blood coagulum compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral. Secondary outcomes from a single-blinded randomized controlled trial.

Clinical oral implants research

Starch-Jensen T, Bruun NH.
PMID: 34608673
Clin Oral Implants Res. 2022 Jan;33(1):65-77. doi: 10.1111/clr.13866. Epub 2021 Oct 14.

OBJECTIVE: The objective was to assess patient's perception of recovery after maxillary sinus membrane elevation (MSME) and blood coagulum (test) compared with maxillary sinus floor augmentation (MSFA) and 1:1 mixture of autogenous bone graft from the buccal antrostomy and...

Cite
Starch-Jensen T, Bruun NH. Patient's perception of recovery after sinus membrane elevation and blood coagulum compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral. Secondary outcomes from a single-blinded randomized controlled trial. Clin Oral Implants Res. 2021;33(1):65-77doi: 10.1111/clr.13866.
Starch-Jensen, T., & Bruun, N. H. (2022). Patient's perception of recovery after sinus membrane elevation and blood coagulum compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral. Secondary outcomes from a single-blinded randomized controlled trial. Clinical oral implants research, 33(1), 65-77. https://doi.org/10.1111/clr.13866
Starch-Jensen, Thomas, and Bruun, Niels Henrik. "Patient's perception of recovery after sinus membrane elevation and blood coagulum compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral. Secondary outcomes from a single-blinded randomized controlled trial." Clinical oral implants research vol. 33,1 (2022): 65-77. doi: https://doi.org/10.1111/clr.13866
Starch-Jensen T, Bruun NH. Patient's perception of recovery after sinus membrane elevation and blood coagulum compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral. Secondary outcomes from a single-blinded randomized controlled trial. Clin Oral Implants Res. 2022 Jan;33(1):65-77. doi: 10.1111/clr.13866. Epub 2021 Oct 14. PMID: 34608673.
Copy Download .nbib Format: NLM
Attractive and Repulsive Exciton-Polariton Interactions Mediated by an Electron Gas.

Physical review letters

Bastarrachea-Magnani MA, Camacho-Guardian A, Bruun GM.
PMID: 33834810
Phys Rev Lett. 2021 Mar 26;126(12):127405. doi: 10.1103/PhysRevLett.126.127405.

Realizing strong photon-photon interactions in a solid-state setting is a major goal with far reaching potential for optoelectronic applications. Using Landau's quasiparticle framework combined with a microscopic many-body theory, we explore the interactions between exciton-polaritons and trions in a...

Cite
Bastarrachea-Magnani MA, Camacho-Guardian A, Bruun GM. Attractive and Repulsive Exciton-Polariton Interactions Mediated by an Electron Gas. Phys Rev Lett. 2021;126(12):127405doi: 10.1103/PhysRevLett.126.127405.
Bastarrachea-Magnani, M. A., Camacho-Guardian, A., & Bruun, G. M. (2021). Attractive and Repulsive Exciton-Polariton Interactions Mediated by an Electron Gas. Physical review letters, 126(12), 127405. https://doi.org/10.1103/PhysRevLett.126.127405
Bastarrachea-Magnani, Miguel A, et al. "Attractive and Repulsive Exciton-Polariton Interactions Mediated by an Electron Gas." Physical review letters vol. 126,12 (2021): 127405. doi: https://doi.org/10.1103/PhysRevLett.126.127405
Bastarrachea-Magnani MA, Camacho-Guardian A, Bruun GM. Attractive and Repulsive Exciton-Polariton Interactions Mediated by an Electron Gas. Phys Rev Lett. 2021 Mar 26;126(12):127405. doi: 10.1103/PhysRevLett.126.127405. PMID: 33834810.
Copy Download .nbib Format: NLM
Trends in Hospital Lawsuits Filed Against Patients for Unpaid Bills Following Published Research About This Activity.

JAMA network open

Paturzo JGR, Hashim F, Dun C, Boctor MJ, Bruhn WE, Walsh C, Bai G, Makary MA.
PMID: 34424301
JAMA Netw Open. 2021 Aug 02;4(8):e2121926. doi: 10.1001/jamanetworkopen.2021.21926.

IMPORTANCE: Suing patients and garnishing their wages for unpaid medical bills can be a predatory form of financial activity that may be inconsistent with the mission of a hospital. Many hospitals in the state of Virginia were discovered to...

Cite
Paturzo JGR, Hashim F, Dun C, et al. Trends in Hospital Lawsuits Filed Against Patients for Unpaid Bills Following Published Research About This Activity. JAMA Netw Open. 2021;4(8):e2121926doi: 10.1001/jamanetworkopen.2021.21926.
Paturzo, J. G. R., Hashim, F., Dun, C., Boctor, M. J., Bruhn, W. E., Walsh, C., Bai, G., & Makary, M. A. (2021). Trends in Hospital Lawsuits Filed Against Patients for Unpaid Bills Following Published Research About This Activity. JAMA network open, 4(8), e2121926. https://doi.org/10.1001/jamanetworkopen.2021.21926
Paturzo, Joseph Giuseppe R, et al. "Trends in Hospital Lawsuits Filed Against Patients for Unpaid Bills Following Published Research About This Activity." JAMA network open vol. 4,8 (2021): e2121926. doi: https://doi.org/10.1001/jamanetworkopen.2021.21926
Paturzo JGR, Hashim F, Dun C, Boctor MJ, Bruhn WE, Walsh C, Bai G, Makary MA. Trends in Hospital Lawsuits Filed Against Patients for Unpaid Bills Following Published Research About This Activity. JAMA Netw Open. 2021 Aug 02;4(8):e2121926. doi: 10.1001/jamanetworkopen.2021.21926. PMID: 34424301; PMCID: PMC8383135.
Copy Download .nbib Format: NLM
JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy.

The Journal of experimental medicine

McGraw JM, Thelen F, Hampton EN, Bruno NE, Young TS, Havran WL, Witherden DA.
PMID: 34427588
J Exp Med. 2021 Oct 04;218(10). doi: 10.1084/jem.20202644. Epub 2021 Aug 24.

T cells are critical mediators of antitumor immunity and a major target for cancer immunotherapy. Antibody blockade of inhibitory receptors such as PD-1 can partially restore the activity of tumor-infiltrating lymphocytes (TILs). However, the activation signals required to promote...

Cite
McGraw JM, Thelen F, Hampton EN, et al. JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy. J Exp Med. 2021;218(10)doi: 10.1084/jem.20202644.
McGraw, J. M., Thelen, F., Hampton, E. N., Bruno, N. E., Young, T. S., Havran, W. L., & Witherden, D. A. (2021). JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy. The Journal of experimental medicine, 218(10), . https://doi.org/10.1084/jem.20202644
McGraw, Joseph M, et al. "JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy." The Journal of experimental medicine vol. 218,10 (2021). doi: https://doi.org/10.1084/jem.20202644
McGraw JM, Thelen F, Hampton EN, Bruno NE, Young TS, Havran WL, Witherden DA. JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy. J Exp Med. 2021 Oct 04;218(10). doi: 10.1084/jem.20202644. Epub 2021 Aug 24. PMID: 34427588; PMCID: PMC8404475.
Copy Download .nbib Format: NLM
Demographic differences in performance validity test failure.

Applied neuropsychology. Adult

Braun SE, Fountain-Zaragoza S, Halliday CA, Horner MD.
PMID: 34428386
Appl Neuropsychol Adult. 2021 Aug 24;1-9. doi: 10.1080/23279095.2021.1958814. Epub 2021 Aug 24.

OBJECTIVE: The present study investigated demographic differences in performance validity test (PVT) failure in a Veteran sample.METHOD: Data were extracted from clinical neuropsychological evaluations. Only veterans who identified as men, as either European American/White (EA) or African American/Black (AA)...

Cite
Braun SE, Fountain-Zaragoza S, Halliday CA, et al. Demographic differences in performance validity test failure. Appl Neuropsychol Adult. 2021;1-9doi: 10.1080/23279095.2021.1958814.
Braun, S. E., Fountain-Zaragoza, S., Halliday, C. A., & Horner, M. D. (2021). Demographic differences in performance validity test failure. Applied neuropsychology. Adult, 1-9. https://doi.org/10.1080/23279095.2021.1958814
Braun, Sarah Ellen, et al. "Demographic differences in performance validity test failure." Applied neuropsychology. Adult vol. (2021): 1-9. doi: https://doi.org/10.1080/23279095.2021.1958814
Braun SE, Fountain-Zaragoza S, Halliday CA, Horner MD. Demographic differences in performance validity test failure. Appl Neuropsychol Adult. 2021 Aug 24;1-9. doi: 10.1080/23279095.2021.1958814. Epub 2021 Aug 24. PMID: 34428386.
Copy Download .nbib Format: NLM
Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus.

Neurotoxicology

Calsbeek JJ, González EA, Boosalis CA, Zolkowska D, Bruun DA, Rowland DJ, Saito NH, Harvey DJ, Chaudhari AJ, Rogawski MA, Garbow JR, Lein PJ.
PMID: 34478772
Neurotoxicology. 2021 Dec;87:43-50. doi: 10.1016/j.neuro.2021.08.011. Epub 2021 Aug 31.

Acute intoxication with tetramethylenedisulfotetramine (TETS) can trigger status epilepticus (SE) in humans. Survivors often exhibit long-term neurological effects, including electrographic abnormalities and cognitive deficits, but the pathogenic mechanisms linking the acute toxic effects of TETS to chronic outcomes are...

Cite
Calsbeek JJ, González EA, Boosalis CA, et al. Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus. Neurotoxicology. 2021;87:43-50doi: 10.1016/j.neuro.2021.08.011.
Calsbeek, J. J., González, E. A., Boosalis, C. A., Zolkowska, D., Bruun, D. A., Rowland, D. J., Saito, N. H., Harvey, D. J., Chaudhari, A. J., Rogawski, M. A., Garbow, J. R., & Lein, P. J. (2021). Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus. Neurotoxicology, 8743-50. https://doi.org/10.1016/j.neuro.2021.08.011
Calsbeek, Jonas J, et al. "Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus." Neurotoxicology vol. 87 (2021): 43-50. doi: https://doi.org/10.1016/j.neuro.2021.08.011
Calsbeek JJ, González EA, Boosalis CA, Zolkowska D, Bruun DA, Rowland DJ, Saito NH, Harvey DJ, Chaudhari AJ, Rogawski MA, Garbow JR, Lein PJ. Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus. Neurotoxicology. 2021 Dec;87:43-50. doi: 10.1016/j.neuro.2021.08.011. Epub 2021 Aug 31. PMID: 34478772; PMCID: PMC8595842.
Copy Download .nbib Format: NLM
Persistent neuropathology and behavioral deficits in a mouse model of status epilepticus induced by acute intoxication with diisopropylfluorophosphate.

Neurotoxicology

Calsbeek JJ, González EA, Bruun DA, Guignet MA, Copping N, Dawson ME, Yu AJ, MacMahon JA, Saito NH, Harvey DJ, Silverman JL, Lein PJ.
PMID: 34509511
Neurotoxicology. 2021 Dec;87:106-119. doi: 10.1016/j.neuro.2021.09.001. Epub 2021 Sep 09.

Organophosphate (OP) nerve agents and pesticides are a class of neurotoxic compounds that can cause status epilepticus (SE), and death following acute high-dose exposures. While the standard of care for acute OP intoxication (atropine, oxime, and high-dose benzodiazepine) can...

Cite
Calsbeek JJ, González EA, Bruun DA, et al. Persistent neuropathology and behavioral deficits in a mouse model of status epilepticus induced by acute intoxication with diisopropylfluorophosphate. Neurotoxicology. 2021;87:106-119doi: 10.1016/j.neuro.2021.09.001.
Calsbeek, J. J., González, E. A., Bruun, D. A., Guignet, M. A., Copping, N., Dawson, M. E., Yu, A. J., MacMahon, J. A., Saito, N. H., Harvey, D. J., Silverman, J. L., & Lein, P. J. (2021). Persistent neuropathology and behavioral deficits in a mouse model of status epilepticus induced by acute intoxication with diisopropylfluorophosphate. Neurotoxicology, 87106-119. https://doi.org/10.1016/j.neuro.2021.09.001
Calsbeek, Jonas J, et al. "Persistent neuropathology and behavioral deficits in a mouse model of status epilepticus induced by acute intoxication with diisopropylfluorophosphate." Neurotoxicology vol. 87 (2021): 106-119. doi: https://doi.org/10.1016/j.neuro.2021.09.001
Calsbeek JJ, González EA, Bruun DA, Guignet MA, Copping N, Dawson ME, Yu AJ, MacMahon JA, Saito NH, Harvey DJ, Silverman JL, Lein PJ. Persistent neuropathology and behavioral deficits in a mouse model of status epilepticus induced by acute intoxication with diisopropylfluorophosphate. Neurotoxicology. 2021 Dec;87:106-119. doi: 10.1016/j.neuro.2021.09.001. Epub 2021 Sep 09. PMID: 34509511; PMCID: PMC8595753.
Copy Download .nbib Format: NLM
Patient's perception of recovery after sinus membrane elevation and blood coagulum compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral. Secondary outcomes from a single-blinded randomized controlled trial.

Clinical oral implants research

Starch-Jensen T, Bruun NH.
PMID: 34608673
Clin Oral Implants Res. 2021 Oct 04; doi: 10.1111/clr.13866. Epub 2021 Oct 04.

OBJECTIVE: The objective was to assess patient's perception of recovery after maxillary sinus membrane elevation (MSME) and blood coagulum (test) compared with maxillary sinus floor augmentation (MSFA) and 1:1 mixture of autogenous bone graft from the buccal antrostomy and...

Cite
Starch-Jensen T, Bruun NH. Patient's perception of recovery after sinus membrane elevation and blood coagulum compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral. Secondary outcomes from a single-blinded randomized controlled trial. Clin Oral Implants Res. 2021;doi: 10.1111/clr.13866.
Starch-Jensen, T., & Bruun, N. H. (2021). Patient's perception of recovery after sinus membrane elevation and blood coagulum compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral. Secondary outcomes from a single-blinded randomized controlled trial. Clinical oral implants research, . https://doi.org/10.1111/clr.13866
Starch-Jensen, Thomas, and Bruun, Niels Henrik. "Patient's perception of recovery after sinus membrane elevation and blood coagulum compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral. Secondary outcomes from a single-blinded randomized controlled trial." Clinical oral implants research vol. (2021). doi: https://doi.org/10.1111/clr.13866
Starch-Jensen T, Bruun NH. Patient's perception of recovery after sinus membrane elevation and blood coagulum compared with 1:1 mixture of autogenous bone graft and deproteinized porcine bone mineral. Secondary outcomes from a single-blinded randomized controlled trial. Clin Oral Implants Res. 2021 Oct 04; doi: 10.1111/clr.13866. Epub 2021 Oct 04. PMID: 34608673.
Copy Download .nbib Format: NLM
Professional and patient-reported outcomes of two surgical approaches for implant-supported single-crown restoration: 1-year results of a randomized controlled clinical trial.

Clinical oral implants research

Nielsen HB, Schou S, Bruun NH, Starch-Jensen T.
PMID: 34866250
Clin Oral Implants Res. 2021 Dec 06; doi: 10.1111/clr.13883. Epub 2021 Dec 06.

OBJECTIVES: To test whether there is a difference in professional and patient-reported outcome measures (PROM) after single-crown restoration supported by short implants (SI) (6 mm) compared with standard length implants (SLI) (13 mm) in conjunction with maxillary sinus floor...

Cite
Nielsen HB, Schou S, Bruun NH, et al. Professional and patient-reported outcomes of two surgical approaches for implant-supported single-crown restoration: 1-year results of a randomized controlled clinical trial. Clin Oral Implants Res. 2021;doi: 10.1111/clr.13883.
Nielsen, H. B., Schou, S., Bruun, N. H., & Starch-Jensen, T. (2021). Professional and patient-reported outcomes of two surgical approaches for implant-supported single-crown restoration: 1-year results of a randomized controlled clinical trial. Clinical oral implants research, . https://doi.org/10.1111/clr.13883
Nielsen, Helle Baungaard, et al. "Professional and patient-reported outcomes of two surgical approaches for implant-supported single-crown restoration: 1-year results of a randomized controlled clinical trial." Clinical oral implants research vol. (2021). doi: https://doi.org/10.1111/clr.13883
Nielsen HB, Schou S, Bruun NH, Starch-Jensen T. Professional and patient-reported outcomes of two surgical approaches for implant-supported single-crown restoration: 1-year results of a randomized controlled clinical trial. Clin Oral Implants Res. 2021 Dec 06; doi: 10.1111/clr.13883. Epub 2021 Dec 06. PMID: 34866250.
Copy Download .nbib Format: NLM
Showing 193 to 203 of 203 entries